"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Bianca Harvey lived a healthy and athletic lifestyle and was shocked to be diagnosed with colon cancer at 33. Now, she vows ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A New England Journal of Medicine study published April 27 found success in administering dostarlimab, an immunotherapy drug, ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy, today announced new clinical and translational data from the ongoing ...

Published in the New England Journal of Medicine (NEJM) and presented simultaneously at the 2025 American Association for Cancer Research Annual Meeting, the results demonstrate t ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in ...